Correlation Between Salesforce and Memphis Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Salesforce and Memphis Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Salesforce and Memphis Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Salesforce and Memphis Pharmaceuticals, you can compare the effects of market volatilities on Salesforce and Memphis Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Salesforce with a short position of Memphis Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Salesforce and Memphis Pharmaceuticals.

Diversification Opportunities for Salesforce and Memphis Pharmaceuticals

0.67

Correlation Coefficient

Salesforce  Memphis Pharmaceuticals

Poor diversification

The 3 months correlation between Salesforce and Memphis is 0.67. Overlapping area represents the amount of risk that can be diversified away by holding Salesforce and Memphis Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Memphis Pharmaceuticals and Salesforce is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Salesforce are associated (or correlated) with Memphis Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Memphis Pharmaceuticals has no effect on the direction of Salesforce i.e., Salesforce and Memphis Pharmaceuticals go up and down completely randomly.

Pair Corralation between Salesforce and Memphis Pharmaceuticals

Considering the 90-day investment horizon Salesforce is expected to generate 1.47 times less return on investment than Memphis Pharmaceuticals. But when comparing it to its historical volatility, Salesforce is 2.97 times less risky than Memphis Pharmaceuticals. It trades about 0.07 of its potential returns per unit of risk. Memphis Pharmaceuticals is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  5,391  in Memphis Pharmaceuticals on October 11, 2024 and sell it today you would lose (301.00) from holding Memphis Pharmaceuticals or give up 5.58% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	78.13%
Values	Daily Returns

Salesforce  vs.  Memphis Pharmaceuticals

Salesforce

Risk-Adjusted Performance

8 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Salesforce are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating basic indicators, Salesforce displayed solid returns over the last few months and may actually be approaching a breakup point.

Memphis Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Memphis Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's technical and fundamental indicators remain nearly stable which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Pair Trading with Salesforce and Memphis Pharmaceuticals

The main advantage of trading using opposite Salesforce and Memphis Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Salesforce position performs unexpectedly, Memphis Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Memphis Pharmaceuticals will offset losses from the drop in Memphis Pharmaceuticals' long position.

The idea behind Salesforce and Memphis Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.